(Q43622152)

25 November 2017

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese (English)

1 reference

25 November 2017

Jing Dong

1

1 reference

25 November 2017

Binhui Ren

2

1 reference

25 November 2017

Zhibin Hu

3

1 reference

25 November 2017

Jiaping Chen

4

1 reference

25 November 2017

Lingmin Hu

5

1 reference

25 November 2017

Juncheng Dai

6

1 reference

25 November 2017

Guangfu Jin

7

1 reference

25 November 2017

Lin Xu

8

1 reference

25 November 2017

Hongbing Shen

9

1 reference

25 November 2017

25 January 2011

1 reference

25 November 2017

Molecular Carcinogenesis

1 reference

25 November 2017

50

1 reference

25 November 2017

433-438

1 reference

25 November 2017

6

1 reference

Global cancer statistics, 2002

25 November 2017

1 reference

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

21 January 2018

1 reference

The p53 network in lung carcinogenesis.

21 January 2018

1 reference

Genetic and epigenetic alterations in colon cancer

21 January 2018

1 reference

Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson

21 January 2018

1 reference

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

21 January 2018

1 reference

Mdm-2: "big brother" of p53.

21 January 2018

1 reference

The p53-Mdm2 module and the ubiquitin system.

21 January 2018

1 reference

The p53 pathway: positive and negative feedback loops

21 January 2018

1 reference

Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53

21 January 2018

1 reference

Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

21 January 2018

1 reference

Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein

21 January 2018

1 reference

Interaction between the retinoblastoma protein and the oncoprotein MDM2

21 January 2018

1 reference

The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis

21 January 2018

1 reference

Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore

21 January 2018

1 reference

Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors

21 January 2018

1 reference

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

21 January 2018

1 reference

A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population

21 January 2018

1 reference

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.

21 January 2018

1 reference

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

21 January 2018

1 reference

Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.

21 January 2018

1 reference

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect

21 January 2018

1 reference

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

21 January 2018

1 reference

Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.

21 January 2018

1 reference

Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer

21 January 2018

1 reference

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer

21 January 2018

1 reference

The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells

21 January 2018

1 reference

MDM2Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.20727

1 reference

25 November 2017

1 reference